Are you over 18 and want to see adult content?
More Annotations
![A complete backup of bannersdontwork.com](https://www.archivebay.com/archive2/b856943c-ef45-42f0-a086-b78262a41174.png)
A complete backup of bannersdontwork.com
Are you over 18 and want to see adult content?
![A complete backup of cernosatyre.tumblr.com](https://www.archivebay.com/archive2/61e1697b-5534-4864-a8d6-e0498eb22053.png)
A complete backup of cernosatyre.tumblr.com
Are you over 18 and want to see adult content?
![A complete backup of conflictnations.com](https://www.archivebay.com/archive2/639f3604-3fe5-4082-b204-35a05bc953d4.png)
A complete backup of conflictnations.com
Are you over 18 and want to see adult content?
![A complete backup of hillsborough-hotel.co.uk](https://www.archivebay.com/archive2/cfae9939-f4ef-4aae-aee2-0d349c3ab6a9.png)
A complete backup of hillsborough-hotel.co.uk
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of nisaba000.wordpress.com](https://www.archivebay.com/archive2/13c5bff7-c5a3-4dd1-9762-ab918996d1e9.png)
A complete backup of nisaba000.wordpress.com
Are you over 18 and want to see adult content?
![A complete backup of caterpillaruniversity.com](https://www.archivebay.com/archive2/f876c5ee-4496-4cbd-83e9-7b59cc2251d3.png)
A complete backup of caterpillaruniversity.com
Are you over 18 and want to see adult content?
![A complete backup of maeckweddings.com](https://www.archivebay.com/archive2/7138139d-ff55-4335-b14f-6ae0a334cf82.png)
A complete backup of maeckweddings.com
Are you over 18 and want to see adult content?
![A complete backup of comoorganizarlacasa.com](https://www.archivebay.com/archive2/1d18e981-1bd4-48ab-9d7c-e44b7830502d.png)
A complete backup of comoorganizarlacasa.com
Are you over 18 and want to see adult content?
Text
SAE_ALF_PREGNANCY
UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2. ICH_GCP_INVESTIGATOR_TRAINING_FOREST_VERSION UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2. INTERVENTIONAL TRIALS_CLINICAL_4NOV2016 Interventional Trials_Clinical_4NOV2016. Safety Reporting in Interventional Trials. Safety Reporting in a Clinical Study. Untitled Slide. Untitled Slide. Site Monitoring. Untitled Slide.SAE_ALF_PREGNANCY
UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2. ICH_GCP_INVESTIGATOR_TRAINING_FOREST_VERSION UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2. INTERVENTIONAL TRIALS_CLINICAL_4NOV2016 Interventional Trials_Clinical_4NOV2016. Safety Reporting in Interventional Trials. Safety Reporting in a Clinical Study. Untitled Slide. Untitled Slide. Site Monitoring. Untitled Slide.SAE_ALF_PREGNANCY
UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2. ICH_GCP_INVESTIGATOR_TRAINING_FOREST_VERSION UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2. INTERVENTIONAL TRIALS_CLINICAL_4NOV2016 Interventional Trials_Clinical_4NOV2016. Safety Reporting in Interventional Trials. Safety Reporting in a Clinical Study. Untitled Slide. Untitled Slide. Site Monitoring. Untitled Slide.SAE_ALF_PREGNANCY
UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2. ICH_GCP_INVESTIGATOR_TRAINING_FOREST_VERSIONFRX DIRECTORYFRX SOFTWAREMICROSOFT FRX DOWNLOADOPEN FRX FILEFRX REPORTINGPHILIPSHEARTSTART FRX AED
UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2. INTERVENTIONAL TRIALS_CLINICAL_4NOV2016OPEN FRX FILEFRX DIRECTORYFRX SOFTWAREMICROSOFT FRX DOWNLOADPHILIPS HEARTSTART FRX AEDFRX REPORTING Interventional Trials_Clinical_4NOV2016. Safety Reporting in Interventional Trials. Safety Reporting in a Clinical Study. Untitled Slide. Untitled Slide. Site Monitoring. Untitled Slide.SAE_ALF_PREGNANCY
UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2. ICH_GCP_INVESTIGATOR_TRAINING_FOREST_VERSIONFRX DIRECTORYFRX SOFTWAREMICROSOFT FRX DOWNLOADOPEN FRX FILEFRX REPORTINGPHILIPSHEARTSTART FRX AED
UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2. INTERVENTIONAL TRIALS_CLINICAL_4NOV2016OPEN FRX FILEFRX DIRECTORYFRX SOFTWAREMICROSOFT FRX DOWNLOADPHILIPS HEARTSTART FRX AEDFRX REPORTING Interventional Trials_Clinical_4NOV2016. Safety Reporting in Interventional Trials. Safety Reporting in a Clinical Study. Untitled Slide. Untitled Slide. Site Monitoring. Untitled Slide.SAE_ALF_PREGNANCY
UPDATED: January 13, 2021. 1. When is the Flash Player end-of-life (EOL)? Adobe stopped supporting Flash Player beginning December 31, 2020 (“ EOL Date ”), as previously announced in July 2017. 2.Global Sites
__
Countries Country SitesCOUNTRIES
COUNTRY SITES
Argentina
Argentina Site __
Australia
Australia Site __
Austria
Austria Site __
Belgium
Belgium Site __
Brazil
Brazil Site __
Canada
Canada Site __
Chile
Chile Site __
China (Mainland)
China (Mainland) Site __Colombia
Colombia Site __
Czech Republic
Czech Republic Site __France
France Site __
Germany
Germany Site __
India
India Site __
Ireland
Ireland Site __
Italy
Italy Site __
Japan
Japan Site __
Korea
Korea Site __
Mexico
Mexico Site __
Netherlands
Netherlands Site __
New Zealand
New Zealand Site __
Poland
Poland Site __
Portugal
Portugal Site __
Russia
Russia Site __
Serbia
Serbia Site __
South Africa
South Africa Site __Spain
Spain Site __
Sweden
Sweden Site __
Switzerland
Switzerland Site __
Taiwan (China)
Taiwan (China) Site __Turkey
Turkey Site __
United Kingdom
United Kingdom Site __United States
United States Site ____ Global / USA
Investors Careers Contact* Products
* Key Therapeutic Areas * Products > Central Nervous System"> Central Nervous System* Key Products
* Products > Central Nervous System > BOTOX®"> BOTOX® (onabotulinumtoxinA)* Product Details
* Products > Central Nervous System > BOTOX® > BOTOX®"> BOTOX® (onabotulinumtoxinA)*
* For Providers
* Products > Central Nervous System > BOTOX® > Prescribing Information, including Boxed Warning"> Prescribing Information, including Boxed Warning __ * Products > Central Nervous System > BOTOX® > Medication Guide">Medication Guide __
* Products > Central Nervous System > BOTOX® > Safety Data Sheet"> Safety Data Sheet __* For Patients
* Products > Central Nervous System > BOTOX® > Patient Assistance Program">Patient Assistance Program*
* Products > Central Nervous System > BOTOX® > botox.com">botox.com __
* Products > Central Nervous System > NAMZARIC®"> NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use* Product Details
* Products > Central Nervous System > NAMZARIC® > NAMZARIC®"> NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use*
* For Providers
* Products > Central Nervous System > NAMZARIC® > Prescribing Information"> Prescribing Information __ * Products > Central Nervous System > NAMZARIC® > Safety Data Sheet"> Safety Data Sheet __* For Patients
* Products > Central Nervous System > NAMZARIC® > Patient Assistance Program">Patient Assistance Program*
* Products > Central Nervous System > NAMZARIC® > namzaric.com">namzaric.com __
* Products > Central Nervous System > UBRELVY™"> UBRELVY™ (ubrogepant) tablets, for oral use* Product Details
* Products > Central Nervous System > UBRELVY™ > UBRELVY™"> UBRELVY™ (ubrogepant) tablets, for oral use*
* For Providers
* Products > Central Nervous System > UBRELVY™ > Prescribing Information"> Prescribing Information __* For Patients
* Products > Central Nervous System > UBRELVY™ > Patient Assistance Program">Patient Assistance Program*
* Products > Central Nervous System > UBRELVY™ > ubrelvy.com">ubrelvy.com __
* Products > Central Nervous System > VRAYLAR®"> VRAYLAR® (cariprazine) capsules, for oral use* Product Details
* Products > Central Nervous System > VRAYLAR® > VRAYLAR®"> VRAYLAR® (cariprazine) capsules, for oral use*
* For Providers
* Products > Central Nervous System > VRAYLAR® > Prescribing Information, including Boxed Warnings"> Prescribing Information, including Boxed Warnings __ * Products > Central Nervous System > VRAYLAR® > Safety Data Sheet"> Safety Data Sheet __* For Patients
* Products > Central Nervous System > VRAYLAR® > Patient Assistance Program">Patient Assistance Program*
* Products > Central Nervous System > VRAYLAR® > vraylar.com">vraylar.com __
*
* Products > Central Nervous System > All Central Nervous System Products">All Central Nervous System Products * Products > Eye Care"> Eye Care* Key Products
* Products > Eye Care > DURYSTA™"> DURYSTA™ (bimatoprost implant)10 mcg
* Product Details
* Products > Eye Care > DURYSTA™ > DURYSTA™"> DURYSTA™ (bimatoprost implant) 10 mcg*
*
* Products > Eye Care > DURYSTA™ > DurystaHCP.com"> DurystaHCP.com__
* Products > Eye Care > LUMIGAN® 0.01%"> LUMIGAN® 0.01% (bimatoprost ophthalmic solution 0.01%)* Product Details
* Products > Eye Care > LUMIGAN® 0.01% > LUMIGAN® 0.01%"> LUMIGAN® 0.01% (bimatoprost ophthalmic solution 0.01%)*
* For Providers
* Products > Eye Care > LUMIGAN® 0.01% > Prescribing Information"> Prescribing Information __* For Patients
* Products > Eye Care > LUMIGAN® 0.01% > Patient Assistance Program">Patient Assistance Program*
* Products > Eye Care > LUMIGAN® 0.01% > lumigan.com"> lumigan.com__
* Products > Eye Care > OZURDEX®"> OZURDEX® (dexamethasone intravitreal implant) 0.7 mg* Product Details
* Products > Eye Care > OZURDEX® > OZURDEX®"> OZURDEX® (dexamethasone intravitreal implant) 0.7 mg*
* For Providers
* Products > Eye Care > OZURDEX® > Prescribing Information"> Prescribing Information __ * Products > Eye Care > OZURDEX® > Safety Data Sheet"> Safety DataSheet __
*
* Products > Eye Care > OZURDEX® > ozurdex.com"> ozurdex.com __ * Products > Eye Care > REFRESH®"> REFRESH® Portfolio of ConsumerEye Care Products
* Product Details
* Products > Eye Care > REFRESH® > REFRESH®"> REFRESH® Portfolio of Consumer Eye Care Products*
*
* Products > Eye Care > REFRESH® > refreshbrand.com">refreshbrand.com __
*
* Products > Eye Care > All Eye Care Products">All Eye Care Products * Products > Gastroenterology"> Gastroenterology* Key Products
* Products > Gastroenterology > LINZESS®"> LINZESS® (linaclotide) capsules, for oral use* Product Details
* Products > Gastroenterology > LINZESS® > LINZESS®"> LINZESS® (linaclotide) capsules, for oral use*
* For Providers
* Products > Gastroenterology > LINZESS® > Prescribing Information, including Boxed Warning"> Prescribing Information, including BoxedWarning __
* Products > Gastroenterology > LINZESS® > Safety Data Sheet"> Safety Data Sheet __* For Patients
* Products > Gastroenterology > LINZESS® > Patient Assistance Program">Patient Assistance Program*
* Products > Gastroenterology > LINZESS® > linzess.com">linzess.com __
* Products > Gastroenterology > VIBERZI®"> VIBERZI® (eluxadoline) tablets, for oral use, CIV* Product Details
* Products > Gastroenterology > VIBERZI® > VIBERZI®"> VIBERZI® (eluxadoline) tablets, for oral use, CIV*
* For Providers
* Products > Gastroenterology > VIBERZI® > Prescribing Information"> Prescribing Information __ * Products > Gastroenterology > VIBERZI® > Safety Data Sheet"> Safety Data Sheet __* For Patients
* Products > Gastroenterology > VIBERZI® > Patient Assistance Program">Patient Assistance Program*
* Products > Gastroenterology > VIBERZI® > viberzi.com">viberzi.com __
*
* Products > Gastroenterology > All Gastroenterology Products">All Gastroenterology Products * Products > Medical Aesthetics"> Medical Aesthetics* Key Products
* Products > Medical Aesthetics > BOTOX® Cosmetic"> BOTOX® Cosmetic (onabotulinumtoxinA)* Product Details
* Products > Medical Aesthetics > BOTOX® Cosmetic > BOTOX® Cosmetic"> BOTOX® Cosmetic (onabotulinumtoxinA)*
* For Providers
* Products > Medical Aesthetics > BOTOX® Cosmetic > Prescribing Information, including Boxed Warning"> Prescribing Information, including Boxed Warning __ * Products > Medical Aesthetics > BOTOX® Cosmetic > Medication Guide"> Medication Guide __ * Products > Medical Aesthetics > BOTOX® Cosmetic > Safety Data Sheet"> Safety Data Sheet __*
* Products > Medical Aesthetics > BOTOX® Cosmetic > botoxcosmetic.com"> botoxcosmetic.com __ * Products > Medical Aesthetics > COOLSCULPTING®"> COOLSCULPTING®* Product Details
* Products > Medical Aesthetics > COOLSCULPTING® > COOLSCULPTING®"> COOLSCULPTING®*
*
* Products > Medical Aesthetics > COOLSCULPTING® > coolsculpting.com"> coolsculpting.com __ * Products > Medical Aesthetics > JUVÉDERM® Ultra"> JUVÉDERM®Ultra
* Product Details
* Products > Medical Aesthetics > JUVÉDERM® Ultra > JUVÉDERM® Ultra"> JUVÉDERM® Ultra*
* For Providers
* Products > Medical Aesthetics > JUVÉDERM® Ultra > Directions for Use"> Directions for Use __* For Patients
* Products > Medical Aesthetics > JUVÉDERM® Ultra > Patient Labeling"> Patient Labeling __*
* Products > Medical Aesthetics > JUVÉDERM® Ultra > juvederm.com">juvederm.com __
* Products > Medical Aesthetics > SkinMedica®"> SkinMedica®* Product Details
* Products > Medical Aesthetics > SkinMedica® > SkinMedica®">SkinMedica®
*
*
* Products > Medical Aesthetics > SkinMedica® > skinmedica.com">skinmedica.com __
*
* Products > Medical Aesthetics > All Medical Aesthetics Products">All Medical Aesthetics Products*
* Products > Patient Assistance Programs">Patient AssistancePrograms
* Products > View All Products">View All Products* About
* About > About Allergan"> About Allergan * About > News"> News * About > Executive Leadership"> Executive Leadership * About > Supplier Relations"> Supplier Relations * About > Patent Notices"> Patent Notices * About > Media Resources"> Media Resources* R&D
* R&D > R&D Pipeline"> R&D Pipeline * R&D > Clinical Trials"> Clinical Trials * R&D > Innovation"> Innovation * R&D > Pre-Approval Access"> Pre-Approval Access * Responsibility">Responsibility__
Menu
__ __
Close
__ Global / USA
* Home">Home
*
Products
* Key Therapeutic Areas * Products > Central Nervous System">Central Nervous System * Products > Eye Care">Eye Care * Products > Gastroenterology">Gastroenterology * Products > Medical Aesthetics">Medical Aesthetics * Products > Patient Assistance Programs">Patient AssistancePrograms
* Products > View All Products">View All Products*
About
* About Allergan
* About > About Allergan"> About Allergan * About > News"> News * About > Executive Leadership"> Executive Leadership * About > Supplier Relations"> Supplier Relations * About > Patent Notices"> Patent Notices * About > Media Resources"> Media Resources*
R&D
* R&D > R&D Pipeline"> R&D Pipeline * R&D > Clinical Trials"> Clinical Trials * R&D > Innovation"> Innovation * R&D > Pre-Approval Access"> Pre-Approval Access * Responsibility">Responsibility* Home">Home
* Investors">Investors* Media">Media
* Patients">Patients * Providers">Providers* YPOP">YPOP
* Careers">Careers
* Contact">Contact
* __ Central Nervous System* Key Products
* Products > Central Nervous System > View All Central Nervous System Products"> View All Central Nervous System Products*
* Products > Central Nervous System > BOTOX®"> BOTOX® (onabotulinumtoxinA) * Products > Central Nervous System > NAMZARIC®"> NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use * Products > Central Nervous System > UBRELVY™"> UBRELVY™ (ubrogepant) tablets, for oral use * Products > Central Nervous System > VRAYLAR®"> VRAYLAR® (cariprazine) capsules, for oral use* __ Eye Care
* Key Products
* Products > Eye Care > View All Eye Care Products"> View All EyeCare Products
*
* Products > Eye Care > DURYSTA™"> DURYSTA™ (bimatoprostimplant) 10 mcg
* Products > Eye Care > LUMIGAN® 0.01%"> LUMIGAN® 0.01% (bimatoprost ophthalmic solution 0.01%) * Products > Eye Care > OZURDEX®"> OZURDEX® (dexamethasone intravitreal implant) 0.7 mg * Products > Eye Care > REFRESH®"> REFRESH® Portfolio of ConsumerEye Care Products
* __ Gastroenterology* Key Products
* Products > Gastroenterology > View All Gastroenterology Products"> View All Gastroenterology Products*
* Products > Gastroenterology > LINZESS®"> LINZESS® (linaclotide) capsules, for oral use * Products > Gastroenterology > VIBERZI®"> VIBERZI® (eluxadoline) tablets, for oral use, CIV * __ Medical Aesthetics* Key Products
* Products > Medical Aesthetics > View All Medical Aesthetics Products"> View All Medical Aesthetics Products*
* Products > Medical Aesthetics > BOTOX® Cosmetic"> BOTOX® Cosmetic (onabotulinumtoxinA) * Products > Medical Aesthetics > COOLSCULPTING®"> COOLSCULPTING® * Products > Medical Aesthetics > JUVÉDERM® Ultra"> JUVÉDERM®Ultra
* Products > Medical Aesthetics > SkinMedica®"> SkinMedica®* __Back
* Home
* Practice Resources * Patient Engagement* __Back
* Investors > Investors">Investors * Investors > Events & Presentations">Events & Presentations*
Corporate & Financial Information * Corporate Information: * Investors > Corporate & Financial Information > Executives & Leadership">Executives & Leadership * Investors > Corporate & Financial Information > Corporate Governance">Corporate Governance * Investors > Corporate & Financial Information > Committee Composition">Committee Composition * Investors > Corporate & Financial Information > Committee Charters">Committee Charters * Investors > Corporate & Financial Information > Acquisition of Allergan by AbbVie">Acquisition of Allergan by AbbVie* Financials:
* Investors > Corporate & Financial Information > Annual Reports">Annual Reports * Investors > Corporate & Financial Information > Quarterly Results">Quarterly Results * Investors > Corporate & Financial Information > SEC Filings">SECFilings
* Investors > Corporate & Financial Information > Insider Transactions">Insider Transactions * Investors > Corporate & Financial Information > Proxy Materials">Proxy Materials*
Shareholder Resources * Investors > Shareholder Resources > Shareholder Services & Investor Kit">Shareholder Services & Investor Kit * Investors > Shareholder Resources > Information Request Form">Information Request Form * Investors > Shareholder Resources > Email Alerts">Email Alerts * Investors > Shareholder Resources > Dividends">Dividends * Investors > Shareholder Resources > Investor FAQ">Investor FAQ*
Stock information
* Stock Information
* Investors > Stock information > Stock Information">StockInformation
* Investors > Stock information > Historic Stock Look-Up">HistoricStock Look-Up
* Investors > Stock information > Analyst Coverage">Analyst Coverage * Investors > Stock information > Investment Calculator">InvestmentCalculator
* __Back
* Media > Media">Media * Media > Company Profile">Company Profile * Media > Executive Bios & Photos">Executive Bios & Photos * Media > images">images * Media > Videos">Videos* __Back
* Patients > Patients">Patients* __Back
* Providers > Providers">Providers * Providers > Medical Information Request">Medical InformationRequest
* __Back
* YPOP > YPOP">YPOP
*
Business Resources
* YPOP > Business Resources > Links & Bulletins">Links & Bulletins * YPOP > Business Resources > Market Recovery Index">Market RecoveryIndex
* YPOP > HCP Training & Information">HCP Training & Information * YPOP > Staff Development">Staff Development * YPOP > Patient Engagement">Patient Engagement* __Back
* Careers > Careers">Careers * Careers > Search Careers">Search Careers ALLERGAN IS NOW PART OF ABBVIE TOGETHER, WE ARE BRINGING OVER 30 BRANDS AND LEADERSHIP POSITIONS TO BETTER SERVE PATIENTS TODAY AND INVEST IN THE MEDICINES OF THE FUTURE.Learn More __
__
ALLERGAN AESTHETICS IS NOW AN ABBVIE COMPANY×
On May 8, 2020, AbbVie completed its acquisition of Allergan, which is now part of AbbVie. Content on this site is being reviewed and will be updated as we work through the integration. Click here to learn more about the acquisition.About Allergan
All Products
Contact
Compliance
Privacy
Terms
California Privacy
Sitemap
Copyright © 2020 AllerganX
This website uses cookies and other technologies to personalize content and to show you more personalized ads (for example, Google Ads and Facebook) on this and other websites, as well as provide you with social media features on this website (such as, Facebook, Twitter, LinkedIn). By clicking “Accept” you understand that you are directing Allergan® to disclose your personal information, including internet tracking data (like cookies and the IP address you used to access this website), to these third parties for the purposes statedabove.
You can still use this website if you do not click “Accept,” but your experience may be different. For more information, including information on the categories of third parties to whom we disclose your personal information, please refer to our global privacy policies, available at www.allergan.com/privacy . For additional options please check your browser’s settings.Read More Read Less
Accept
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0